TP63 and cancer: Several studies using IHC for p63 detection found associations with adverse tumour features and poor patient outcome for low p63 expression by analysing 50–1086 cancers,7, 13, 14, 15, 16, 17 whereas one study on 103 cancers found an association between high p63 expression and poor clinical outcome.18